Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening

PLoS ONE - United States
doi 10.1371/journal.pone.0142484
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Lung Cancer Screening With CT

Clinics in Chest Medicine
PulmonaryRespiratory Medicine
2008English

Correction To: CT Screening for Lung Cancer: Comparison of Three Baseline Screening Protocols

European Radiology
MedicineNuclear MedicineRadiologyImaging
2019English

Low-Dose CT for Lung Cancer Screening

The Lancet Oncology
Oncology
2018English

The Potential of Breath Analysis to Improve Outcome for Patients With Lung Cancer

Journal of Breath Research
PulmonaryRespiratory Medicine
2019English

The Regional Association Between Bronchiectasis and Lung Cancer in Chest CT

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2016English

Low-Dose CT for Lung Cancer Screening – Authors' Reply

The Lancet Oncology
Oncology
2018English

A National Survey of Lung Cancer Specialists’ Views on Low-Dose CT Screening for Lung Cancer in Korea

PLoS ONE
Multidisciplinary
2018English

Quality Control of Chest CT Screening by Dedicated Phantom

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2003English

CT Screening for Lung Cancer: Successful Trial, but Failed Understanding

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy